Abstract: This article addresses the problem of secure recursive state estimation for a networked linear system, which may be vulnerable to interception of transmitted measurement data by ...
Abstract: To drive the gyroscope into a command vibration mode, and to simultaneously estimate the angular velocity, this paper proposes an improved fully adjusted neural network-based adaptive ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Best Penny Stocks to Buy with the Highest Upside Potential. On September 10, Gil Blum from Needham reiterated a Buy rating on Recursion ...
In this scene-setting keynote, Sir Martin Sorrell offers a state-of-the-nation address for the marketing industry, reflecting on where it’s heading post-Omnicom-IPG merger approval. He’ll ...
Recursion Pharmaceuticals (NASDAQ: RXRX), a biotech focused on artificial intelligence (AI), became a publicly traded company in 2021 -- a time when AI did not grab nearly as much attention (if any at ...
Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...
Diebold Nixdorf isn't as well-known as BigBear.ai, but it could have better growth prospects. Recursion Pharmaceuticals' AI drug discovery gives it a shot at growing larger than BigBear.ai. Will ...